Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunome Inc
(NQ:
IMNM
)
13.83
-0.57 (-3.96%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunome Inc
< Previous
1
2
3
4
5
Next >
Immunome Appoints Carol A. Schafer to Board of Directors
January 02, 2024
From
Immunome, Inc.
Via
Business Wire
Immunome to Acquire Antibody-Related Assets and Materials from Atreca
December 26, 2023
From
Immunome, Inc.
Via
Business Wire
Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome
December 26, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Immunome to Present at the Stifel 2023 Healthcare Conference
November 10, 2023
From
Immunome, Inc.
Via
Business Wire
Immunome Inc. (NASDAQ: IMNM) Leading the Way in Thursday Trading Based on Percentage Gain
June 29, 2023
Via
Investor Brand Network
Exposures
COVID-19
Why Are Immunome Shares Trading Higher Today
June 29, 2023
Immunome Inc (NASDAQ: IMNM) and Morphimmune have announced a merger agreement in
Via
Benzinga
Immunome Reports Third Quarter 2023 Financial Results
November 09, 2023
From
Immunome, Inc.
Via
Business Wire
Immunome Appoints Jean-Jacques Bienaimé to Board of Directors
November 08, 2023
From
Immunome, Inc.
Via
Business Wire
7 Biotech Stocks to Get In Now Before Investors Catch On
October 23, 2023
Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them.
Via
InvestorPlace
Immunome Appoints Bob Lechleider, M.D., as Chief Medical Officer
October 19, 2023
From
Immunome, Inc.
Via
Business Wire
Immunome: Q1 Earnings Insights
May 05, 2023
Via
Benzinga
Immunome Stock Jumps On Discovery Pact With AbbVie
January 06, 2023
Via
Benzinga
Immunome and Morphimmune Announce Successful Completion of Merger with $125 Million PIPE to Develop Novel Targeted Cancer Therapies
October 03, 2023
From
Immunome, Inc.
Via
Business Wire
Immunome Reports Second Quarter 2023 Financial Results
August 09, 2023
From
Immunome, Inc.
Via
Business Wire
Nasdaq Moves Lower; Acuity Brands Earnings Top Estimates
June 29, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Thursday. The Dow traded up 0.68% to 34,081.83 while the NASDAQ fell 0.23% to 13,560.57. The S&P...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
June 29, 2023
Via
Benzinga
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 29, 2023
Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash.
Via
Benzinga
IMNM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Immunome, Inc. Is Fair to Shareholders
June 29, 2023
From
Halper Sadeh LLC
Via
Business Wire
Immunome (NASDAQ: IMNM) and Morphimmune Announce Merger to Develop Best-in-Class Targeted Cancer Therapies
June 29, 2023
Via
Spotlight Growth
Exposures
Product Safety
Dow Rises Over 100 Points; US GDP Grows 2% In Q1
June 29, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.37% to 33,977.04 while the NASDAQ rose...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 29, 2023
Via
Benzinga
Immunome and Morphimmune Announce Definitive Merger Agreement and Simultaneous Private Placement Investment of $125 Million to Develop Targeted Cancer Therapies
June 29, 2023
From
Immunome
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 28, 2023
Via
Benzinga
Immunome Publishes Preclinical Research Demonstrating that Inhibition of IL-38 Using an Antibody Leads to Anti-Tumor Activity
May 23, 2023
From
Immunome, Inc.
Via
Business Wire
Immunome Reports First Quarter 2023 Financial Results
May 05, 2023
From
Immunome, Inc.
Via
Business Wire
Immunome Reports Fourth Quarter and Full Year 2022 Financial Results
March 16, 2023
From
Immunome, Inc.
Via
Business Wire
Immunome to Present at 13th Annual World ADC London Conference
March 09, 2023
From
Immunome, Inc.
Via
Business Wire
Immunome Announces Formation of Antibody-Drug Conjugate and T Cell Redirection Advisory Board
February 08, 2023
From
Immunome, Inc.
Via
Business Wire
AbbVie Briefly Breaks Out After Tapping Immunome In $30 Million Cancer Deal
January 06, 2023
AbbVie is tapping Immunome to help develop new cancer treatments.
Via
Investor's Business Daily
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 06, 2023
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.